Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Opinion: Even with new law, clinical trials lack data on older adults
By
Kristen Fischer
Apr 17, 2024
Older adults are not represented adequately in clinical trials of medications for disorders that are common in the population. The legal framework to better represent them is in place, but not enough is...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
An Alzheimer’s reality check
By
Tim Mullaney
Nov 12, 2013
Alzheimer’s researchers — or the public relations machines breathlessly trumpeting their work — should chill out. I see so much of this type of Alzheimer’s news that it’s hard to...
Report endorses adding more nursing home residents in clinical trials, shares framework to do so
By
Kristen Fischer
Mar 18, 2024
A commentary published in the Journal of the American Geriatrics Society on March 14 talks about the need for clinical trials among people living in nursing homes.